Balancing oral medicine for clots and bleeds
A new range of oral medicine is now available to treat thrombosis
4th February 2016
Prevention and treatment of thrombosis used to be rather arcane. Three things have brought it back into the centrestage of medical discourse.
First, the realisation that VTE is a leading, yet largely preventable, cause of morbidity and mortality.
Second, the link between atrial fibrillation and stroke is also preventable. AF affects a significant proportion of people over the age of 60, with risk increasing with age.
And finally, a new class of oral anticoagulants are now available, which effectively prevent and treat VTE, and prevent stroke